Estimated Annual Pharmaceutical Revenue Loss Due to Medication Non-Adherence
“Revenue loss for non-adherence is estimated to be $564 billion, or 59% of the $956 billion in total global pharmaceutical revenue. Medication non-adherence is one of the most serious problems in healthcare, posing a heavy financial impact on all constituencies.
For insurers, employers, and patients, non-adherence significantly increases healthcare costs as a result of disease-related complications. For pharmaceutical companies, pharmacies, and pharmacy benefits managers, non-adherence significantly erodes profit due to prescriptions never filled and medications not taken often enough.”Capgemini Consulting & Health Prize.
To read more follow this link http://pharmengage.com/wp-content/uploads/2015/04/Reveneu-loss-for-non-adherence-564report_web.pdf